T Yoshizumi
Overview
Explore the profile of T Yoshizumi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
1475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toshima T, Yoshizumi T, Harada N, Ikegami T, Itoh S, Fujimori N, et al.
J Gastroenterol Hepatol
. 2020 Oct;
35(11):1854.
PMID: 33029802
No abstract available.
2.
Matsumoto T, Itoh S, Yoshizumi T, Kurihara T, Yoshiya S, Mano Y, et al.
BJS Open
. 2020 Sep;
PMID: 32959537
Background: The C-reactive protein : albumin ratio (CAR) has been reported as a novel prognostic marker in several cancers. The aim of this study was to investigate the prognostic value...
3.
Watanabe A, Yoshizumi T, Harimoto N, Kogure K, Ikegami T, Harada N, et al.
Br J Surg
. 2020 Apr;
107(9):1192-1198.
PMID: 32335898
Background: The right hepatic venous system consists of the right hepatic vein (RHV) and inferior RHVs (IRHVs). When the right posterior section is used as a graft for liver transplantation,...
4.
Itoh S, Yugawa K, Shimokawa M, Yoshiya S, Mano Y, Takeishi K, et al.
BJS Open
. 2019 Aug;
3(4):500-508.
PMID: 31388642
Background: Cancer-related inflammation has been correlated with cancer prognosis. This study evaluated inflammatory biomarkers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR), programmed death ligand (PD-L) 1...
5.
Kimura K, Kudo K, Kurihara T, Yoshiya S, Mano Y, Takeishi K, et al.
Transplant Proc
. 2019 Mar;
51(2):579-584.
PMID: 30879594
Cholangitis is a major complication following transplantation. We report a living donor liver transplant (LDLT) patient with cholangitis due to multiple stones in the intrahepatic bile duct during hepaticojejunostomy anastomosis,...
6.
Harimoto N, Nakagawara H, Shirabe K, Yoshizumi T, Itoh S, Ikegami T, et al.
Transplant Proc
. 2018 Dec;
50(10):3858-3862.
PMID: 30577278
Chimeric mice with humanized liver were first established by transplanting primary human hepatocytes (PHHs) isolated from a Japanese 27-year-old donor into complementary DNA-urokinase-type plasminogen activator/severe combined immunodeficiency mice. The PHHs...
7.
Soejima Y, Yoshizumi T, Ikegami T, Harimoto N, Harada N, Itoh S, et al.
Transplant Proc
. 2018 Dec;
50(10):3549-3551.
PMID: 30577235
Thrombectomy is a routine or common practice for treating organized portal vein thrombosis (PVT) during liver transplantation. However, this procedure is often performed in a blinded fashion and can result...
8.
Harimoto N, Yugawa K, Ikegami T, Ohira M, Mano Y, Motomura T, et al.
J Gastroenterol Hepatol
. 2017 Dec;
33(1):9.
PMID: 29284078
No abstract available.
9.
Motomura T, Yoshizumi T, Ohira M, Mano Y, Toshima T, Itoh S, et al.
Transplant Proc
. 2017 Dec;
49(10):2409-2410.
PMID: 29198692
Transplant-associated thrombotic microangiopathy (TA-TMA) is a rare but severe complication after liver transplantation. In contrast to other thrombotic microangiopathies, treatment for TA-TMA has yet to be clarified. A 52-year-old male...
10.
Harimoto N, Yoshizumi T, Izumi T, Motomura T, Harada N, Itoh S, et al.
Transplant Proc
. 2017 Nov;
49(9):2144-2152.
PMID: 29149975
Background: Sarcopenia is an independent predictor of death after living-donor liver transplantation (LDLT). However, the ability of the Asian Working Group for Sarcopenia criteria for sarcopenia (defined as reduced skeletal...